Dependence of heart rate variability on indicators of type 1 diabetes mellitus control.
DOI:
https://doi.org/10.26641/2307-0404.2020.1.200406Keywords:
diabetes mellitus type 1, heart rate variability, control markersAbstract
The aim of our study was to evaluate the influence of the main indicators of type 1 diabetes mellitus (T1DM) control on heart rate variability (HRV). We examined 62 patients at the age of 18-45 years with an average T1DM duration of 11.0 (5.0; 18.0) years. HRV in the time and frequency range was evaluated by analyzing a 24-hour Holter electrocardiogram (ECG). The following laboratory parameters were used as markers of course and compensation of T1DM: C-peptide, HbA1c, blood creatinine, albuminuria (AU), estimated glomerular filtration rate (eGFR) by CKD-EPI formula. In addition, the maximum and minimum blood glucose levels and the blood glucose range (maximum minus minimum blood glucose values) were conducted by continuous glucose monitoring system iPro2 (Medtronic MiniMed, USA). The daily monitoring of electrocardiogram (ECG) was made in parallel with long term monitoring of blood glucose. Echocardiography in all patients was performed to exclude organic heart disease and the possibility of its influence on HRV. Poor control of T1DM negatively influences HRV through decrease in both frequency and time characteristics. The blood glucose range can be an additional negative factor for cardiovascular system in T1DM patients, regardless of HbA1c, whereas it positively correlates with HRV- relative hypersympathicotonia markers: LF/HF 24-h, ρ=0.43 (p<0.05), LF/HF day ρ=0.37 (p<0.05), ρ=0.38 LF/HF night. Diabetic nephropathy is another factor of cardiovascular disease progression in T1DM, since its criteria have reliably negative (for eGFR) and positive (for AU) correlations of mean force with all HRV characteristics. Selected markers of T1DM control cause 45, 73% of variance in HRV, mainly affecting TP 24-h, TP daytime, VLF 24-h, VLF daytime. Reduction of these frequency HRV characteristics may indicate autonomic neuropathy in patients with poor control of T1DM.
References
Moskalenko VF, Gulchiy OP, Colubchikov MV. [Biostatistika]. Kyiv: Knigaplus; 2009 p. 184. Ukrainian.
Lytovskyi MN. [Statistical, visual and morphological aspects of the diabetes effect on the cardiovascular system]. Naukovyi visnyk Uzhogodskogo universytetu, Seriia: Medytsyna; 2017;55(1):168-77. Ukrainian.
[Order of HM Ukraine from 29.12.2014 N 1021. The unified clinical protocols of primary, secondary (specialized) and tertiary (highly specialized) medical care. Type 1 diabetes in young people and adults ]. Kyiv; 2014. Ukrainian.
Agashe S, Petak S. Cardiac Autonomic Neuropathy in Diabetes Mellitus. Methodist Debakey Cardiovasc J. 2018;14(4):251-6. doi: doi.org/10.14797/mdcj-14-4-251
Pop-Busui R, Braffett BH, Zinman B, Martin C, White NH, Herman WH, Genuth S, Gubitosi-Klug R. DCCT/EDIC Research Group. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care. 2017;40(1):94-100. doi: https://doi.org/10.2337/dc16-1397
Cygankiewicz I, Zareba W. Heart rate variability. Handb Clin Neurol. 2013;117:379-93. doi: https://doi.org/10.1016/B978-0-444-53491-0.00031-6
Madonna R, Balistreri CR, Geng YJ, De Caterina R. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches. Vascul Pharmacol. 2017;90:1-7. doi: https://doi.org/10.1016/j.vph.2017.01.004
Fisher VL, Tahrani AA. Cardiac autonomic neuropathy in patients with diabetes mellitus: Current perspectives. Diabetes Metab Syndr Obes. 2017;10:419-34. doi: https://doi.org/10.2147/DMSO.S129797
Bishop SA, Dech RT, Guzik P, Neary JP. Heart rate variability and implication for sport concussion. Clin Physiol Funct Imaging. 2018;38(5):733-42. doi: https://doi.org/10.1111/cpf.12487
Hillebrand S, Gast KB, de Mutsert R, Swenne CA, Jukema JW, Middeldorp S, Rosendaal FR, Dekkers OM. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013;15(5) :742-9. doi: https://doi.org/10.1093/europace/eus341
Varma U, Koutsifeli P, Benson VL, Mellor KM, Delbridge LMD. Molecular mechanisms of cardiac pathology in diabetes – Experimental insights. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;1864(5 Part B):1949-59. doi: https://doi.org/10.1016/j.bbadis.2017.10.035
Shaffer F, and Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017;5:258. doi: https://doi.org/10.3389/fpubh.2017.00258
Spallone V. Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet. Diabetes Metab J. 2019;43(1):3-30. doi: https://doi.org/10.4093/dmj.2018.0259
American Diabetes Assosiation: Standards of Medical Care in Diabetes –2016. Diabetes Care. 2016;39(1). doi: https://doi.org/10.2337/dc16-S003
Silva LE, Silva CA, Salgado HC, Fazan RJr. The role of sympathetic and vagal cardiac control on complexity of heart rate dynamics. Am J Physiol Heart Circ Physiol. 2017;312(3):H469-77. doi: https://doi.org/10.1152/ajpheart.00507.2016
Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, Hajizadeh-Saffar E, Farhadi A, Shapiro AMJ, Tahamtani Y, Baharvand H. Type 1 diabetes mellitus: cellular and molecular pathophysiology at a glance. Cell J. 2018;20(3):294-301. doi: https://doi.org/10.22074/cellj.2018.5513
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.